Financhill
Back

RAPT Therapeutics Stock Predictions

RAPT Therapeutics Stock Forecast

  • Is RAPT Therapeutics Stock Undervalued?
    The current RAPT Therapeutics [RAPT] share price is $1.62. The Score for RAPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • RAPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will RAPT Therapeutics Stock Go Up Next Year?

Data Unavailable

RAPT Therapeutics Stock Rating

Data Unavailable

RAPT Therapeutics Stock Price History

Is RAPT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rapt.com

52-Week Data

52-Week High:
27.35
52-Week Low:
0.79

Prediction Charts

Market Cap:
56.6M
Price in USD:
1.62
Volume:
2.1M
Beta:
0.21

Technical Analysis

SMA50:
1.51
SMA100:
1.78
SMA200:
3.59
52-Wk Change:
-93.48%

Stock Predictions

  • Is RAPT Therapeutics stock public?
    Yes, RAPT Therapeutics is a publicly traded company.
  • What is the RAPT Therapeutics stock quote today?
    The RAPT Therapeutics stock price is 1.62 USD today.
  • How to buy RAPT Therapeutics stock online?
    You can buy RAPT Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-10 1.16 1.09 1.16 1.09
Dec-11 1.12 1.09 1.12 1.07
Dec-12 1.09 1.03 1.12 1.01
Dec-13 1.03 0.91 1.04 0.91
Dec-16 0.92 0.88 0.96 0.88
Dec-17 0.86 0.84 0.89 0.84
Dec-18 0.85 0.82 0.93 0.81
Dec-19 0.82 0.81 0.85 0.79
Dec-20 0.80 0.84 0.88 0.80
Dec-23 1.52 1.74 2.32 1.46
Dec-24 1.59 1.73 1.81 1.55
Dec-26 1.95 1.81 2.09 1.72
Dec-27 1.82 1.69 1.94 1.69
Dec-30 1.71 1.62 1.76 1.55

RAPT Therapeutics Earnings

Data Unavailable

RAPT Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and a decrease next year of $1.87 per share.

* RAPT Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.